Astrazeneca Pharma India Ltd Share Price
(ASTRAZEN)
₹8607.65▲1.33%
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 25.51 % |
3 Month Return | + 19.62 % |
1 Year Return | + 65.51 % |
Market Stats | |
Previous Close | ₹8,494.65 |
Open | ₹8,510.00 |
Volume | 30.40K |
Upper Circuit | ₹10,193.55 |
Lower Circuit | ₹6,795.75 |
Market Cap | ₹21,519.13Cr |
P/E Ratio
0PEG Ratio
0Market Cap
₹21,519.13 Cr
P/B Ratio
18.68
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
24.84
AstraZeneca Faces Tax Challenge Amid Strong Stock Momentum - 19 Mar, 2025
Trading Recommendation for Astrazeneca Pharma - 12 Mar, 2025
AstraZeneca Pharma India Reports Strong Growth - 11 Mar, 2025
AstraZeneca Gains Approval for Lung Cancer Drug - 07 Mar, 2025
AstraZeneca Gains Approval for New Hyperkalaemia Drug - 06 Mar, 2025
AstraZeneca Shares Surge Amid Positive Momentum - 05 Mar, 2025
AstraZeneca Pharma Secures CDSCO Approval for Cancer Drug - 03 Mar, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 2.90% to 2.93% in Dec 2024 quarter
Best in 3 Years
In the last 3 years, ASTRAZEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 1 month, ASTRAZEN stock has moved up by 25.5%
Best in 1 Year
In the last 1 year, ASTRAZEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.00% of holdings in Dec 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 5.05% to 5.04% in Dec 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 17.00% to 16.85% in Dec 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 75% | 0.00 | |
Foreign Institutions | 2.93% | 1.02 | |
Mutual Funds | 5.04% | ||
Retail Investors | 16.85% | ||
Others | 0.18% | 270.61 |
Astrazeneca Pharma India Ltd’s net profit jumped 95.25% since last year same period to ₹30.85Cr in the Q3 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -19.72% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Astrazeneca Pharma India Ltd has declared dividend of ₹24 - translating a dividend yield of 0.46%.
Read More about DividendsBearish
Neutral
Bullish
Astrazeneca Pharma India Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹21,519.13 Cr | 51.46% | 0.51 | NA | NA | |
BUY | ₹29,300.43 Cr | 193.09% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹14,271.69 Cr | 57.79% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹4,800.00 Cr | 10.26% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹14,234.50 Cr | 42.27% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Astrazeneca Pharma India Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Astrazeneca Pharma India Ltd share price today stands at ₹8607.65, Open: ₹8510, Previous Close: ₹8494.65, High: ₹8759, Low: ₹8430.3, 52 Week High: ₹9059.05, 52 Week Low: ₹4800.15.
Today's traded volume of Astrazeneca Pharma India Ltd(ASTRAZEN) is 30.40K.
Today's market capitalisation of Astrazeneca Pharma India Ltd(ASTRAZEN) is ₹21519.13Cr.
Astrazeneca Pharma India Ltd (ASTRAZEN) share price is ₹8607.65. It is down -4.98% from its 52 Week High price of ₹9059.05
Astrazeneca Pharma India Ltd (ASTRAZEN) share price is ₹8607.65. It is up 79.32% from its 52 Week Low price of ₹4800.15